Enhancing (hyperemic) peripheral inner rim (increased vascularity)
Nonenhancing peripheral outer rim or “halo” (avascular rim)
Delayed or nonenhancing central part of tumor (myxoid and hyalinized stroma)
•
Imaging protocol: Multiphasic CT or MR
•
Spectrum of growth in lesions may be seen: Nodular form (more common); diffuse or extensive form (very rare)
TOP DIFFERENTIAL DIAGNOSES
•
Peripheral cholangiocarcinoma
•
Focal confluent fibrosis
•
Hemangioma (especially in cirrhotic liver)
PATHOLOGY
•
Slowly progressing, low-grade, malignant vascular tumor of liver
Most patients survive 5-10 years after diagnosis
•
Must not be confused with infantile hemangioendothelioma
Benign primary vascular liver tumor
Resolves spontaneously in many cases
DIAGNOSTIC CHECKLIST
•
Usually located at periphery with extension to capsule
•
Typical capsular retraction of peripheral tumor (due to fibrosis and ischemia)
Rule out other hepatic lesions that typically cause capsular retraction
•
“Target” appearance on CECT or MR
•
Differentiated from other lesions by tumor cells staining positive for factor VIII-related antigen
TERMINOLOGY
Abbreviations
•
Epithelioid hemangioendothelioma (EHE)
Synonyms
•
Hepatic epithelioid hemangioendothelioma
Definitions
•
Primary malignant tumor of liver arising from vascular elements of mesenchymal tissue
IMAGING
General Features
•
Best diagnostic clue
Coalescent peripheral hepatic nodules with target-like appearance and capsular retraction
•
Location
Liver
–
Periphery (> 75%) with extension to capsule
Locations other than liver
–
Soft tissues, bone, and lung
•
Size
Varies from small tumor nodules to large confluent masses
•
Key concepts
Rare primary malignant (low-grade) vascular tumor of liver in adults
Other primary malignant vascular tumors of liver
–
Angiosarcoma (2% of all primary malignant liver tumors)
–
Kaposi sarcoma: Metastatic vascular tumor in AIDS and transplant recipients
All hepatic malignant vascular tumors
–
Share histologic characteristics
–
Grow around and into vessels
Clinical course
–
Less aggressive than angiosarcomas or hepatocellular carcinoma, but still fatal in most cases
–
Variable and unpredictable
–
Metastatic in 40% of cases (spleen, mesentery, lymph nodes, lung, bone)
CT Findings
•
Spectrum of growth in lesions may be seen
Nodular form (more common)
–
Multiple liver nodules coalesce to form large, confluent masses
Diffuse or extensive form (very rare)
•
Usually located at periphery with extension to capsule
•
Capsular retraction (due to tumor fibrosis and ischemia) or flattening; segmental volume loss
•
Occasional calcification within tumor
•
Compensatory hypertrophy
Uninvolved liver (usually left lobe)
•
May have extrahepatic metastases and ascites
•
NECT
Tumor nodules
–
Foci of homogeneous decreased attenuation (due to myxoid stroma) compared to normal liver parenchyma
Conspicuity and extent of lesions
•
CECT
Target-like enhancement pattern of tumor
–
Delayed or nonenhancing central part of tumor (myxoid and hyalinized stroma)
–
Enhancing (hyperemic) peripheral inner rim (increased vascularity)
–
Nonenhancing peripheral outer rim or “halo” (avascular rim)
MR Findings
•
T1WI
Lesions are hypointense centrally
Peripheral, thin, hypointense rim
•
T2WI
Hyperintense centrally
Peripheral, thin, hypointense rim
•
T1WI C+
“Target” pattern: 3 concentric layers of alternating signal intensity (analogous to CECT appearance)
–
Periphery: Thick, enhancing, inner rim and thin, nonenhancing, outer rim
Ultrasonographic Findings
Get Clinical Tree app for offline access